Health Score

0 Good

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Add abstracts to 36 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact36 DOIs

Attach ORCID iDs across 9 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact9 DOIs

DOIs for this ISSN

Showing the top 5 of 36 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Newcastle disease virus in poultry with an interface as a hu… (10.1016/j.vetvac.2022.100003)	Abstract ORCID	55.70	12
2	Progress and challenges for developing vaccines against gast… (10.1016/j.vetvac.2023.100041)	Abstract ORCID	50.00	9
3	Research progress of the avian coccidiosis vaccine (10.1016/j.vetvac.2022.100002)	Abstract ORCID	47.71	8
4	Vaccination of calves at day of birth with attenuated vaccin… (10.1016/j.vetvac.2023.100014)	Abstract ORCID	45.15	7
5	Molecular mechanisms of suppression of host innate immunity… (10.1016/j.vetvac.2023.100015)	Abstract ORCID	38.91	5
6	Assessing immune evasion potential and vaccine suitability o… (10.1016/j.vetvac.2024.100067)	Abstract ORCID	38.91	5
7	The first commercially approved efficacious cryptosporidium… (10.1016/j.vetvac.2024.100054)	Abstract	36.56	28
8	Rabies vaccines: Journey from classical to modern era (10.1016/j.vetvac.2025.100105)	Abstract	26.03	10
9	Design of multiepitope vaccine candidate from a major capsid… (10.1016/j.vetvac.2023.100013)	Abstract	23.86	8
10	ASFV antigens selected from genotype I immunised pigs are im… (10.1016/j.vetvac.2023.100042)	Abstract	23.86	8
11	In-silico vaccine matching and its validation through in-viv… (10.1016/j.vetvac.2023.100029)	Abstract	22.58	7
12	Efficacy of a plant-produced clade 2.3.4.4 H5 influenza viru… (10.1016/j.vetvac.2022.100001)	Abstract	21.13	6
13	Vaccine delivery: Overcoming the challenges of vaccinating l… (10.1016/j.vetvac.2024.100093)	Abstract	21.13	6
14	Vaccine epidemiology, evaluation, and constraints of vaccine… (10.1016/j.vetvac.2022.100004)	Abstract	19.45	5
15	Conserved proteins of Eimeria and their applications to deve… (10.1016/j.vetvac.2024.100068)	Abstract	17.47	4
16	Poly(I:C), a double stranded RNA analog, activates the anti-… (10.1016/j.vetvac.2023.100016)	Abstract	15.05	3
17	Progress on the poxvirus vaccine (10.1016/j.vetvac.2024.100092)	Abstract ORCID	15.05	1
18	CD205-targeted bispecific nanobody enhances antigen presenta… (10.1016/j.vetvac.2025.100131)	Abstract	15.05	3
19	Comparison of predicted T cell epitopes in porcine circoviru… (10.1016/j.vetvac.2023.100028)	Abstract	11.93	2
20	Preclinical evaluation of a recombinant MVA expressing the h… (10.1016/j.vetvac.2023.100027)	Abstract	7.53	1
21	The past, present and future of duck plague virus vaccines (10.1016/j.vetvac.2025.100104)	Abstract	7.53	1
22	Efficacy of intranasal vaccines containing bovine corona vir… (10.1016/j.vetvac.2025.100106)	Abstract	7.53	1
23	Immunogenicity of a recombinant vaccine against Lawsonia int… (10.1016/j.vetvac.2025.100132)	Abstract	7.53	1
24	An octavalent dendrimer of multiple antigenic peptide with a… (10.1016/j.vetvac.2024.100055)	Abstract	0.00	0
25	Immunization of mice with delayed lysis Salmonella expressin… (10.1016/j.vetvac.2024.100069)	Abstract	0.00	0
26	Effect of period supplementation of Saccharomyces boulardii… (10.1016/j.vetvac.2024.100081)	Abstract	0.00	0
27	Serum antibody titers against distemper, parvovirus and infe… (10.1016/j.vetvac.2025.100107)	Abstract	0.00	0
28	Development of a baculovirus-derived chimeric virus-like par… (10.1016/j.vetvac.2025.100119)	Abstract ORCID	0.00	0
29	Vaccination protocols according to World Small Animal Veteri… (10.1016/j.vetvac.2025.100120)	Abstract	0.00	0
30	Isolation and molecular characterization of antibiotic resis… (10.1016/j.vetvac.2025.100133)	Abstract	0.00	0
31	Toward the Development of a Live Attenuated Vaccine: Constru… (10.1016/j.vetvac.2025.100145)	Abstract	0.00	0
32	Comprehensive immunoinformatics approach for developing a mu… (10.1016/j.vetvac.2025.100146)	Abstract	0.00	0
33	Current landscape and domestic breakthroughs: A comprehensiv… (10.1016/j.vetvac.2026.100158)	Abstract ORCID	0.00	0
34	Evaluation of the safety and protective efficacy of an ILTV… (10.1016/j.vetvac.2026.100159)	Abstract	0.00	0
35	Pan-genomic entropy profiling reveals conserved immune hotsp… (10.1016/j.vetvac.2026.100160)	Abstract	0.00	0
36	The epidemiological and evolutionary dynamics of Getah virus… (10.1016/j.vetvac.2026.100172)	Abstract	0.00	0